|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Ammunition Sales | |||||
| Marketplace Fee Revenue | |||||
| Ammunition Casings Sales | |||||
| Total net revenues | |||||
| Cost of revenues | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| Selling and marketing | |||||
| Corporate general and administrative | |||||
| Employee salaries and related expenses | |||||
| Depreciation and amortization expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other Income (Expense) | |||||
| Interest and other income | |||||
| Gain on extinguishment of debt | |||||
| Interest expense | |||||
| Total other income, net | |||||
| Loss before income taxes from continuing operations | |||||
| Provision for income taxes | |||||
| Net Income/(Loss) | |||||
| Net loss from continuing operations | |||||
| Preferred stock dividend | |||||
| Net loss before discontinued operations, net of tax | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net loss attributable to common stock shareholders | |||||
| Basic income (loss) per share of common stock: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Total basic loss per share of common stock | |||||
| Diluted income (loss) per share of common stock: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Total diluted loss per share of common stock | |||||
| Weighted average number of shares outstanding | |||||
| Basic | |||||
| Diluted | |||||
Loading...